entertainment -WSS

entertainment

author：focus 2025-10-02 15:43:37 - browse：265

KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced by patients with a genetic condition called hereditary angioedema achieved the goals of a Phase 3 clinical trial.

Based on the study results, the company plans to submit a marketing application to the Food and Drug Administration by the middle of the year. Regulatory filings in Europe and Japan will be completed later in the year.

In the Phase 3 study involving 136 participants, a low and high dose of Kalvista’s drug, called sebetralstat, showed a median time to the beginning of symptom relief of 1.6 hours and 1.8 hours, respectively, compared to 6.7 hours for a placebo. The result was statistically significant and achieved the study’s main efficacy goal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： AI gets buy

explore

WSS

Unique patient identifier: Experts argue the benefits, pitfalls

The CDC's new social media misinformation war

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

ACA's risk program benefits Blue Cross Blue Shield insurers

Devoted Health’s losses in Medicare Advantage persist

Recent heat wave in the Mediterranean caused by climate change: Study

knowledge

entertainment

focus

Guidelines to prevent youth baseball injuries need more muscle

What’s missing from the debate over nursing home staff minimums

Medicare details structure of new drug price negotiation program

Home health providers sue Medicare over payment cuts

What does generative AI mean for health care? We asked experts

Problems with a popular proposal to regulate AI in health care

The high cost of giving birth even with insurance

Bernie brings in new pharma CEOs to talk drug prices

DIEP, the 'gold standard' of breast reconstruction, is under threat

AI gets buy

hotspot

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

AI gets buy

Surgery pushed Ben Carson to fame

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Bernie brings in new pharma CEOs to talk drug prices

leisure time

hotspot

explore

focus